UPB
Upstream Bio, Inc.
5.20$
-0.4%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -776.0% | -3,580.0% | -2,744.1% | -1,575.7% | -2,300.2% | -3,199.3% | -7,273.0% | -4,187.7% | -3,256.2% | -4,585.5% | -4,627.9% | -4,608.2% | -4,317.4% | |
| 2.7% | 3.1% | 2.0% | 2.5% | 2.3% | 8.0% | 7.6% | 4.5% | -414.1% | 880.8% | -68.2% | 6.5% | 76.0% | |
| 110.0% | 180.7% | 100.5% | 276.9% | 306.9% | 340.3% | 465.5% | 277.2% | 379.8% | 375.1% | 449.4% | 563.3% | 446.5% | |
| 492.3% | -895.1% | -603.6% | 1,242.5% | 118.1% | -215.0% | -2,645.2% | -113.7% | 1,300.0% | 1,159.7% | -1,098.1% | -56.9% | 153.0% | |
| 0.0% | 0.0% | 0.0% | 0.0% | 53.7% | 30.2% | 0.0% | 5.0% | 6.9% | 7.0% | 0.0% | 0.0% | 3.0% | |
| 1,972.5% | -1,164.9% | 2,164.4% | -22,873.3% | 232.1% | 6,836.5% | -37,699.8% | 1,363.2% | 7,055.1% | 8,823.7% | 4,100.6% | 2,038.9% | 5,234.0% | |
| 8.1% | -29.6% | 1,466.7% | 27,552.2% | -270.3% | 44,151.4% | -6.0% | 65.3% | 111.3% | 165.1% | 57.8% | 327.7% | 158.1% | |
| 1,204.5% | -4,774.4% | 887.0% | 3,103.1% | -2,338.4% | 47,788.6% | -44,978.8% | -2,759.2% | 3,910.1% | 4,403.3% | -469.4% | -2,241.5% | 1,074.7% | |
| -776.0% | -3,580.0% | -2,744.1% | -1,575.7% | -2,353.9% | -3,229.5% | -7,273.0% | -4,192.7% | -3,249.3% | -4,592.5% | -4,627.9% | -4,608.2% | -4,317.4% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.